|
1. FRANCE
Collection/compilation agency: MENRT (Ministère de l’éducation nationale, de la recherche et de la technologie – Bureau des études statistiques sur la recherche) and INRA/SERD (Institut National de la Recherche Agronomique)
Collection/compilation type: A biotechnology firm survey was developed in collaboration with INRA (Institut National de la Recherche Agronomique). Prior to this survey MENRT commissioned a study by Arthur Andersen to set up a register of enterprises.
Variables:
-
Name of the firm and key top executives
-
Main technologies developed and implemented by the company (list of 33 technologies)
-
Main areas of business (markets) in which the company operates (list of 28 markets)
-
Revenues, R&D expenditure, net earnings and work force over the last three years
-
Patents used and owned by the company
-
Quality certification
-
Actual and targeted partnerships in fields of research, production and marketing
Scope: Public academic laboratories and private enterprises
Frequency: Annual
Periodicity: Annual
Classification used: See Definition used
Definition used: Rather than defining biotechnology France has established a list of 35 biotechnologies (available in French only at present):
Amplification de gènes - PCR
ADN recombinant
Anticorps monoclonaux
Bioinformatique
Bioprocess
Biopuces
Bio-réacteur
Chimie chorale
Chimie combinatoire
Contrôle des procédés
Criblage de molécules haut débit
Culture des tissus ou des cellules
Enzymologie
Fermentation
Fonctionnalisation des gènes
Galénique
Hormones et facteurs de croissance
Hybridation, fusion cellulaire
Ingénierie des glucides
Ingénierie des lipides
Ingénierie des protéines
Ingénierie des tissus
Instrumentation
Isolation de peptides et synthèse
Modélisation moléculaire
Molécules antisens
Pharmacogénomique
Protéomique
Purification/séparation
Séquençage
Synthèse des molécules
Système de délivrance (vecteurs)
Traitements des produits et substituts sanguins
Transgénèse
Autres : préciser :
Output:
Biofutur, Bio industry: the European Dream, (February 2000)
INRA, Is The Creation And Development Of Biotechnology SMEs Localised?, by S. Lemarié, V. Magematin, A. Torre (2000)
INRA, Strategies Of European SMEs In Biotechnology: The Role Of Size, Technology And Market?, by S. Lemarié, M.-A. de Looze, V. Mangematin (2000)
Contact comments: France counts approximately 1 000 biotechnology units of which approximately 700 are public academic laboratories and the remainder private enterprises. The survey was sent out to these labs and enterprises.
Of all the companies to which the questionnaire was sent, less than 450 corresponded to the final criteria. It can therefore be considered that the sample analysed corresponds to around half of the biotechnology firms operating in France. The analysis was based on 194 firms, for which all the requested information was available.
Future plans (plans for new collections, strategies, experiences etc.): N/A
Contact details: http://biotech.education.fr/apropos.asp
2. FRANCE
Collection/compilation agency: MENRT (Ministère de l’éducation nationale, de la recherche et de la technologie – Bureau des études statistiques sur la recherche)
Collection/compilation type: A biotechnology firm survey was developed along the OECD recommendations.
Variables:
-
Name of the firm
-
Address
-
NACE code
-
Activity portfolio
-
R&D work force in 2001
-
External R&D, R&D execution for an other company, for itself
-
Public human and material supports
-
The technological level of firms against national and international competitors
Scope: Private enterprises
Frequency: Annual
Periodicity: Onetime study for 2001
Classification used: N/A
Definition used: OECD definition of biotechnology. The following is the French translation: La biotechnologie est définie par l’utilisation de techniques impliquant du matériel vivant : servant à modifier des organismes vivants existants ou des parties de ceux-ci ou ; servant à transformer du matériel, d’origine vivante ou non, par l’utilisation de procédés impliquant des organismes vivants et ayant pour objectif de produire de nouvelles connaissances (scientifiques) ou de développer de nouveaux produits ou procédés.
Output: Les entreprises de biotechnologies en France en 2001: http://cisad.adc.education.fr/reperes/telechar/nr/nr0301.pdf
Contact comments: By exploiting the responses to the mandatory annual R&D survey the survey has identified 650 biotechnology firms. Through the unique identification number of the firm, the biotechnology firms can be cross-referenced against all the available national surveys and data sets (CIS3, Patent, fiscal files etc.). Usual variables such as age, turnover can be determined upon request.
Future plans (plans for new collections, strategies, experiences etc.): N/A
Contact details: http://cisad.adc.education.fr/reperes/default.htm
Survey attached in annex
3. FRANCE
Collection/compilation agency: MENRT (Ministère de l’éducation nationale, de la recherche et de la technologie – Bureau des études statistiques sur la recherche)
Collection/compilation type: R&D Survey was developed along the OECD recommendations.
Variable:
Scope: Private enterprises
Frequency: Since 2000
Periodicity: Annual
Classification used: N/A
Definition used: OECD definition of biotechnology. The following is the French translation: «Les biotechnologies : on rappelle la définition de l’OCDE : «application des principes de la science et de l’ingénierie au traitement de matières par des agents biologiques dans la production de biens et de services».
Quelques exemples (non exhaustifs) de biotechnologies : ADN recombinant, amplification de l’ADN, thérapie génique, anticorps monoclonaux, génie génétique, séquençage, biovalorisation, bioinformatique, enzymologie, fermentation, …».
Output:
Recherche et développement en France - Résultats 2000, estimations 2001, 2003
http://cisad.adc.education.fr/reperes/telechar/res/res00/dossier00.pdf
Contact comments: Pharmaceutical firms tend to put 100% of their activities in biotechnology since biotechnology is the closest R&D branch that is proposed (see below). 401 firms gave a positive answer for 2001.
Future plans (plans for new collections, strategies, experiences etc.):
Contact details: http://cisad.adc.education.fr/reperes/default.htm
|
